| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |